|
Volumn 109, Issue 9, 2014, Pages 1443-1449
|
Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
ANASTOMOSIS;
ARTICLE;
COLON;
COLON DISEASE;
CROHN DISEASE;
DRUG ANTAGONISM;
DUODENUM DISEASE;
FEMALE;
FOLLOW UP;
HUMAN;
ILEUM;
INTESTINE FISTULA;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
RETROSPECTIVE STUDY;
SKIN FISTULA;
SMALL INTESTINE;
TIME;
TREATMENT OUTCOME;
YOUNG ADULT;
ADULT;
ANASTOMOSIS, SURGICAL;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
COLON;
COLONIC DISEASES;
CROHN DISEASE;
CUTANEOUS FISTULA;
DUODENAL DISEASES;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
ILEUM;
INTESTINAL FISTULA;
INTESTINE, SMALL;
MALE;
MIDDLE AGED;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
YOUNG ADULT;
|
EID: 84908238297
PISSN: None
EISSN: 15720241
Source Type: Journal
DOI: 10.1038/ajg.2014.183 Document Type: Article |
Times cited : (62)
|
References (0)
|